carbamazepine has been researched along with Panic Disorder in 19 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Panic Disorder: A type of anxiety disorder characterized by unexpected panic attacks that last minutes or, rarely, hours. Panic attacks begin with intense apprehension, fear or terror and, often, a feeling of impending doom. Symptoms experienced during a panic attack include dyspnea or sensations of being smothered; dizziness, loss of balance or faintness; choking sensations; palpitations or accelerated heart rate; shakiness; sweating; nausea or other form of abdominal distress; depersonalization or derealization; paresthesias; hot flashes or chills; chest discomfort or pain; fear of dying and fear of not being in control of oneself or going crazy. Agoraphobia may also develop. Similar to other anxiety disorders, it may be inherited as an autosomal dominant trait.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation." | 9.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
| "A number of preclinical studies and preliminary clinical reports, in some cases augmented by controlled studies, suggest that valproate and carbamazepine may have therapeutic effects in the treatment of certain anxiety disorders (panic disorder, post-traumatic stress disorder), alcohol and sedative-hypnotic withdrawal states, and behavioral dyscontrol syndromes." | 8.78 | Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. ( Friedman, LM; Keck, PE; McElroy, SL, 1992) |
| "This analysis is a retrospective chart review evaluating the safety of carbamazepine (CBZ) extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) when used in combination with other agents as part of a polypharmacy regimen in the treatment of patients with bipolar disorder." | 7.73 | Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy. ( Ginsberg, LD, 2006) |
| "This study was designed to examine the possibility that patients with panic disorder are especially vulnerable to alprazolam withdrawal, as well as to evaluate the efficacy of carbamazepine as adjunctive treatment during alprazolam discontinuation." | 5.07 | Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. ( Colin, V; Klein, E; Lenox, RH; Stolk, J, 1994) |
| "Evidence from preclinical studies, preliminary clinical reports, pharmacologic challenge studies and a small number of controlled trials suggests that several antiepileptic agents--valproate, carbamazepine, and clonazepam--may have therapeutic effects in the treatment of patients with panic disorder." | 4.78 | Antiepileptic drugs for the treatment of panic disorder. ( Bennett, JA; Keck, PE; McElroy, SL; Smith, JM; Tugrul, KC, 1993) |
| "A number of preclinical studies and preliminary clinical reports, in some cases augmented by controlled studies, suggest that valproate and carbamazepine may have therapeutic effects in the treatment of certain anxiety disorders (panic disorder, post-traumatic stress disorder), alcohol and sedative-hypnotic withdrawal states, and behavioral dyscontrol syndromes." | 4.78 | Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes. ( Friedman, LM; Keck, PE; McElroy, SL, 1992) |
| "Maternal epilepsy treated with carbamazepine and migraine were found to be associated with higher risk of ventricular septal defect; panic disorders were associated with higher risk of hypoplastic left heart; type I diabetes mellitus was associated with higher risk of coarctation of the aorta; chronic hypertension was associated with higher risk of ventricular septal defect, common atrioventricular canal and common truncus; and paroxysmal supraventricular tachycardia was associated with higher risk of atrial septal defect secundum, common atrioventricular canal and ventricular septal defect." | 3.80 | Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study. ( Czeizel, AE; Gerencsér, B; Szabó, I; Vereczkey, A, 2014) |
| "This analysis is a retrospective chart review evaluating the safety of carbamazepine (CBZ) extended-release capsules (CBZ-ERC) (Shire, Wayne, PA, USA) when used in combination with other agents as part of a polypharmacy regimen in the treatment of patients with bipolar disorder." | 3.73 | Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy. ( Ginsberg, LD, 2006) |
| " In this paper we describe two patients with comorbid epilepsy, major depression, and panic disorder, whose serum citalopram levels increased and antidepressant response changed when concurrent carbamazepine treatment was substituted with oxcarbazepine." | 3.69 | Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases. ( Koponen, H; Leinonen, E; Lepola, U, 1996) |
| " Under the treatment with carbamazepine panic attacks improved." | 3.69 | [Panic attacks with cycloleptic course--differential diagnostic considerations in differentiating panic disorder from epileptic anxiety attacks]. ( Assion, HJ; Heinemann, F, 1996) |
| "Complex partial epilepsy can be mistaken for primary child-psychiatric disorder." | 1.35 | [Panic attacks simulated by occipital lobe seizures]. ( Püst, B; Sieben, C; Stolle, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (73.68) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vereczkey, A | 1 |
| Gerencsér, B | 1 |
| Czeizel, AE | 1 |
| Szabó, I | 1 |
| Ramos-Zúñiga, R | 1 |
| Pérez-Gómez, HR | 1 |
| Gaytán-Martínez, LA | 1 |
| Vega-Ruiz, B | 1 |
| Soto-Rodríguez, S | 1 |
| Rochín-Mozqueda, A | 1 |
| Stolle, M | 1 |
| Sieben, C | 1 |
| Püst, B | 1 |
| Ginsberg, LD | 1 |
| Himmerich, H | 1 |
| Nickel, T | 1 |
| Dalal, MA | 1 |
| Müller, MB | 1 |
| Dantendorfer, K | 3 |
| Amering, M | 2 |
| Baischer, W | 1 |
| Berger, P | 1 |
| Steinberger, K | 1 |
| Windhaber, J | 2 |
| Katschnig, H | 2 |
| Roy-Byrne, PP | 1 |
| Sullivan, MD | 1 |
| Cowley, DS | 1 |
| Ries, RK | 1 |
| Klein, E | 1 |
| Colin, V | 1 |
| Stolk, J | 1 |
| Lenox, RH | 1 |
| Schüler, P | 1 |
| Kalb, R | 1 |
| Keck, PE | 2 |
| McElroy, SL | 2 |
| Tugrul, KC | 1 |
| Bennett, JA | 1 |
| Smith, JM | 1 |
| Weilburg, JB | 1 |
| Schachter, S | 1 |
| Sachs, GS | 1 |
| Worth, J | 1 |
| Pollack, MH | 1 |
| Ives, JR | 1 |
| Schomer, DL | 1 |
| Laidlaw, JD | 1 |
| Leinonen, E | 1 |
| Lepola, U | 1 |
| Koponen, H | 1 |
| Heinemann, F | 1 |
| Assion, HJ | 1 |
| Kaendler, SH | 1 |
| Volk, S | 1 |
| Pflug, B | 1 |
| Prayer, D | 1 |
| Maierhofer, D | 2 |
| Schnider, P | 1 |
| Friedman, LM | 1 |
| McNamara, ME | 1 |
| Fogel, BS | 1 |
3 reviews available for carbamazepine and Panic Disorder
| Article | Year |
|---|---|
Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
Topics: Anti-Anxiety Agents; Benzodiazepines; Carbamazepine; Clonidine; Combined Modality Therapy; Humans; P | 1993 |
Antiepileptic drugs for the treatment of panic disorder.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Humans; Panic Disorder; Valproic Acid | 1993 |
Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes.
Topics: Carbamazepine; Humans; Mental Disorders; Panic Disorder; Stress Disorders, Post-Traumatic; Substance | 1992 |
1 trial available for carbamazepine and Panic Disorder
| Article | Year |
|---|---|
Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Topics: Adult; Alprazolam; Anxiety Disorders; Carbamazepine; Double-Blind Method; Drug Administration Schedu | 1994 |
15 other studies available for carbamazepine and Panic Disorder
| Article | Year |
|---|---|
Association of certain chronic maternal diseases with the risk of specific congenital heart defects: a population-based study.
Topics: Adult; Anticonvulsants; Aortic Coarctation; Carbamazepine; Case-Control Studies; Chronic Disease; Di | 2014 |
[Temporal lobe epilepsy and active neurocysticercosis: two representative case reports].
Topics: Albendazole; Anomia; Anthelmintics; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Citalopram | 2015 |
[Panic attacks simulated by occipital lobe seizures].
Topics: Anticonvulsants; Anxiety Disorders; Carbamazepine; Child; Combined Modality Therapy; Compulsive Beha | 2009 |
Safety of carbamazepine extended-release capsules in bipolar disorder polypharmacy.
Topics: Adolescent; Adult; Aged; Antimanic Agents; Anxiety Disorders; Attention Deficit Disorder with Hypera | 2006 |
[Gabapentin treatment in a female patient with panic disorder and adverse effects under carbamazepine during benzodiazepine withdrawal].
Topics: Aged; Alprazolam; Amines; Antimanic Agents; Benzodiazepines; Carbamazepine; Chemical and Drug Induce | 2007 |
Is there a pathophysiological and therapeutic link between panic disorder and epilepsy?
Topics: Adult; Brain; Carbamazepine; Electroencephalography; Epilepsy; Female; Humans; Magnetic Resonance Im | 1995 |
[Anxiety attacks and epileptic seizures. Determining similarities based on a case report].
Topics: Adult; Arousal; Carbamazepine; Dose-Response Relationship, Drug; Electroencephalography; Epilepsy; E | 1994 |
Focal paroxysmal EEG changes during atypical panic attacks.
Topics: Adult; Brain; Brain Diseases; Carbamazepine; Clonazepam; Electroencephalography; Female; Humans; Mag | 1993 |
Epilepsy mistaken for panic attacks in an adolescent girl.
Topics: Adolescent; Carbamazepine; Diagnosis, Differential; Electroencephalography; Epilepsies, Partial; Fem | 1993 |
Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Carbamazepine; Citalopram; Depressive Disorder; Drug | 1996 |
[Panic attacks with cycloleptic course--differential diagnostic considerations in differentiating panic disorder from epileptic anxiety attacks].
Topics: Anticonvulsants; Anxiety Disorders; Carbamazepine; Diagnosis, Differential; Epilepsy, Temporal Lobe; | 1996 |
[Benzodiazepine withdrawal with carbamazepine].
Topics: Adult; Anti-Anxiety Agents; Anticonvulsants; Arousal; Benzodiazepines; Carbamazepine; Delayed-Action | 1996 |
Treatment of Koro and panic attacks after stroke.
Topics: Anticonvulsants; Carbamazepine; Cerebral Cortex; Cerebral Infarction; Clonazepam; Drug Therapy, Comb | 1996 |
Oxcarbazepine for panic disorder occurring after two grand mal seizures: a case report.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy, Tonic-Clonic; Humans; Male; Oxcarbazepine; Panic Di | 1997 |
Anticonvulsant-responsive panic attacks with temporal lobe EEG abnormalities.
Topics: Adolescent; Adult; Anticonvulsants; Brain Damage, Chronic; Carbamazepine; Clonazepam; Electroencepha | 1990 |